1,015
Participants
Start Date
July 31, 2007
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
Placebo
9g /day (3 times a day)
AST-120
9g /day (3 times a day)
Tuscaloosa
Hot Springs
Bakersfield
Glendale
Los Angeles
Palo Alto
Riverside
Denver
Boynton Beach
West Palm Beach
Augusta
Macon
Honolulu
Evergreen Park
Shawnee Mission
Kenner
Shreveport
Pontiac
Brooklyn Center
Flushing
Great Neck
New York
Williamsville
Elizabeth City
Cincinnati
Bend
Allentown
Doylestown
Lancaster
Providence
Charleston
Columbia
Orangeburg
Sumter
Knoxville
Nashville
Dallas
Houston
Arlington
Fairfax
Norfolk
Richmond
Suffolk
Vancouver
Morgantown
Milwaukee
Buenos Aires
Córdoba
San Miguel de Tucumán
Belo Horizonte
Botucatu
Campinas
Curitiba
Ibirapuera
Porto Alegre
Rio de Janeiro
São Paulo
Sorocaba
Calgary
Vancouver
Greenfield Park
Montreal
Hradec Králové
Liberec
Prague
Ústí nad Labem
Hamburg
Kiel
Mainz
Aguascalientes
Cuernavaca
Durango
Mexico City
México
Bialystok
Częstochowa
Lublin
Warsaw
San Juan
Arkhangelsk
Chelyabinsk
Kemerovo
Moscow
Novosibirsk
Orenburg
Petrozavodsk
Saint Petersburg
Saratov
Tomsk
Yaroslayl
Yekaterinburg
A Coruña
Asturias
Barcelona
Guadalajara
Madrid
Ivano-Frankivsk
Kharkiv
Kiev
Luhansk
Lviv
Mykolayiv
Poltava
Ternopil
Vinnitsa
Zaporizhzhya
Lead Sponsor
Collaborators (1)
Kureha Corporation
INDUSTRY
Mitsubishi Tanabe Pharma Corporation
INDUSTRY